Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor-Reference-Cited by-同舟云学术

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

Published:1998-09-29 Issue:20 Volume:95 Page:12022-12027
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Fry D. W.,Bridges A. J.,Denny W. A.,Doherty A.,Greis K. D.,Hicks J. L.,Hook K. E.,Keller P. R.,Leopold W. R.,Loo J. A.,McNamara D. J.,Nelson J. M.,Sherwood V.,Smaill J. B.,Trumpp-Kallmeyer S.,Dobrusin E. M.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference46 articles.

1. A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling

2. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

3. HER‐2/ neu Signal Transduction in Human Breast and Ovarian Cancer

4. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation

5. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

Cited by 395 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative stress-mediated protein sulfenylation in human diseases: Past, present, and future;Redox Biology;2024-10

2. Recent advances in the design of small molecular drugs with acrylamides covalent warheads;Bioorganic & Medicinal Chemistry;2024-10

3. Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents;Current Medicinal Chemistry;2024-06-10

4. Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update;Journal of Medicinal Chemistry;2024-05-07

5. Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors;Journal of Medicinal Chemistry;2023-12-22